Dihydrocodeine
- TRADE NAME: DHC-Continus (Napp)
- INDICATIONS: Severe pain in cancer and other chronic conditions
- CLASS: Analgesic; opioid
- HALF-LIFE: 12 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
CNS depressants, MAO inhibitors, phenothiazines, tranquilizers
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
OCULAR.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 03/13/2024
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric